Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
North South Ventures is a seed-stage venture capital fund established to invest in companies that enhance patient health and improve healthcare systems. Founded in prominent medical research hubs, specifically Stanford/UCSF and the University of Toronto, the firm is strategically positioned to identify and support innovative healthcare startups. The firm has a strong commitment to backing entrepreneurs who are developing groundbreaking solutions in the healthcare sector.
Currently, North South Ventures manages a portfolio of over 800 companies, with a cumulative funding amount exceeding $4 billion. The firm has achieved notable milestones, including the backing of 23 unicorns and over 100 FDA approvals. Their investment strategy is focused on early-stage opportunities, particularly in the biotech and healthtech sectors, which are critical for advancing healthcare delivery and patient outcomes.
North South Ventures operates from its office located at 2443 Fillmore St, San Francisco, CA. The firm’s extensive network in the healthcare sector allows it to provide strategic guidance and facilitate connections with key stakeholders, enhancing the potential for success among its portfolio companies.
North South Ventures primarily targets early-stage investment opportunities in the biotech and healthtech sectors. The firm seeks startups that have the potential to significantly improve patient outcomes, enhance healthcare delivery, or reduce administrative burdens within the healthcare sector. Their investment strategy emphasizes innovative solutions that can drive growth and transformation in healthcare.
The firm focuses on pre-seed, seed, and seed-plus stages, making it well-suited for startups in their formative phases. North South Ventures is particularly interested in companies that are developing technologies such as AI-driven cancer treatments, advanced genetic screening technologies, and digital health tools aimed at personalized healthcare. This strategic focus allows the firm to identify and support startups that align with its mission of improving patient health and healthcare systems.
North South Ventures has invested in over 800 companies, resulting in 23 unicorns and more than 100 FDA approvals. The portfolio includes a diverse range of innovative healthcare solutions:
David Naylor, MD, PhD - President Emeritus and Former Dean of Medicine at the University of Toronto. He brings extensive experience in medical research and healthcare leadership.
Ilse Treurnicht, PhD - Former CEO of MaRS Discovery District, known for her expertise in innovation and entrepreneurship in the healthcare sector.
Paul Kudlow, MD, PhD - Co-founder of TrendMD, with a background in medical technology and healthcare startups.
Andrew Lee, MD, PhD - Co-founder of Clipboard Health, specializing in healthcare technology and operational efficiency.
To pitch North South Ventures, founders should submit their proposals via email at info@northsouthvc.com. The pitch deck should include a clear overview of the business model, market opportunity, competitive landscape, and team qualifications. Founders are encouraged to provide data supporting their claims and any relevant traction metrics.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In recent months, North South Ventures has continued to expand its portfolio, actively investing in innovative healthcare solutions. Notable investments include a non-hormonal male contraceptive pill and AI-developed T-cell receptors for cancer treatment. The firm has also celebrated the achievement of over 100 FDA approvals across its portfolio, underscoring its commitment to supporting groundbreaking healthcare innovations.
As of March 2026, North South Ventures remains a key player in the healthcare investment space, leveraging its extensive network and expertise to drive growth in the sector.
What are North South Ventures' investment criteria?
North South Ventures focuses on seed-stage investments in healthcare-related startups that aim to improve patient health and enhance healthcare systems. They look for innovative solutions in biotech and healthtech that can significantly impact patient outcomes.
How can I apply or pitch to North South Ventures?
Interested parties can submit a pitch via email at info@northsouthvc.com. It is advisable to include a detailed business plan and information about the team and technology.
What makes North South Ventures different from other VC firms?
The firm has a strong presence in leading medical research hubs, which allows them to identify and support innovative healthcare startups effectively. Their focus on healthcare innovation and extensive network in the sector provides unique advantages to portfolio companies.
What is the geographic scope of North South Ventures?
North South Ventures primarily invests in North America, with a specific focus on the United States. Their investments are concentrated in regions with strong medical research capabilities.
What is the typical check size for investments?
While specific check sizes are not disclosed, North South Ventures focuses on early-stage investments, which typically range from pre-seed to seed-plus funding rounds.
What kind of post-investment involvement does North South Ventures have?
The firm adds value to its portfolio companies by providing strategic guidance, leveraging its extensive network, and facilitating connections with key stakeholders in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.